REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 185 filers reported holding REPLIGEN CORP in Q1 2017. The put-call ratio across all filers is 3.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,439,000 | +38.8% | 182,912 | +21.5% | 0.09% | +20.5% |
| Q4 2016 | $4,639,000 | +35.9% | 150,525 | +33.1% | 0.07% | +17.7% |
| Q3 2016 | $3,414,000 | +39.3% | 113,082 | +26.3% | 0.06% | +24.0% |
| Q2 2016 | $2,450,000 | +35.1% | 89,535 | +32.5% | 0.05% | +25.0% |
| Q1 2016 | $1,813,000 | -0.4% | 67,589 | +5.0% | 0.04% | -20.0% |
| Q4 2015 | $1,821,000 | +22.5% | 64,361 | +20.6% | 0.05% | +22.0% |
| Q3 2015 | $1,487,000 | -17.3% | 53,378 | +22.6% | 0.04% | -6.8% |
| Q2 2015 | $1,797,000 | -16.4% | 43,533 | -38.5% | 0.04% | -21.4% |
| Q1 2015 | $2,149,000 | +91.2% | 70,783 | +24.7% | 0.06% | +93.1% |
| Q4 2014 | $1,124,000 | +279.7% | 56,779 | +282.2% | 0.03% | +262.5% |
| Q3 2014 | $296,000 | +29.8% | 14,855 | +48.3% | 0.01% | +14.3% |
| Q2 2014 | $228,000 | +28.1% | 10,018 | -27.5% | 0.01% | +16.7% |
| Q1 2014 | $178,000 | -16.4% | 13,810 | -11.4% | 0.01% | -14.3% |
| Q4 2013 | $213,000 | – | 15,588 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |